speb/financial-data huggingface dataset:
Financial scorecard for ZIP (Communication Services — Internet Content & Information, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 3.9
Market cap: 317937952 (USD: 317937952)
Debt to equity: -6.6541234898046895
Current ratio: 7.27
Interest coverage ratio: -0.20789685737308622
Buffett classification: The Gruesome
Analyst consensus upside (%): 117.3913043478261
Rule of 40 score: -16.76621014549979
Altman Z-score: 1.0853905757548294 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 2.998383785273927
Debt paydown yield (%): 0.09593066762913538
Total shareholder yield (%): 3.0943144529030624 (Low Return)
Momentum (%): 1m 17.824773413897276, 3m 31.313131313131304, 6m 45.52238805970148, 12m -15.032679738562091, composite 16.316269711060453 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 17, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -2.2877390632807915
Revenue deceleration: no
Accrual ratio: 0.001694928862051524
FCF conversion rate: 1.2005065428450823
Beneish M-score: -2.5403398509083592 (Likely Safe)
Net margin (%): -4.40551572800729
Asset turnover: 0.19187843613374236
ROE archetype: Standard Business
FCF z-score: 4.813004920340472
Treasury beta 1y: 0.011825411939962715 (R-squared: 0.0033278531928464354)
Insider 90-day net shares: -163426 (net value USD: -538825.00)
ROIC (%): -21.43562788220288 (pretax: -27.133706180003642)
Incremental ROIC 3y (%): -180.88196616134897 (pretax: -219.6751582755502)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B , ROIC 61.15702479338842, revenue growth 1y 35.53719008264463, 6m momentum 4.132231404958678
Sector percentiles: P/E , 6m momentum 4.312449145646868
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.06921779893542837
Base cash flow: -21610000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1541.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.4145408163265306
Market cap: 1396800256 (USD: 199542893.7142857)
P/B ratio: 2.784773161739518
Debt to equity: 0.28859999999999997
Current ratio: 3.84
Interest coverage ratio: -40.19928355957768
Return on net tangible assets (%): -25.93800896344245
Buffett classification: The Gruesome
Analyst consensus upside (%): 739.2808219178082
Rule of 40 score: -25.362759131299228
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -6.9637612964783395
Total shareholder yield (%): -6.9637612964783395 (Minimal or Negative)
Momentum (%): 1m -11.684782608695656, 3m -35.852676050657415, 6m -32.3552642814448, 12m -69.18422908936303, composite -44.43833529519878 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.4772369957489153 (Likely Safe)
Equity multiplier (leverage): 1.4117881371272816
ROE archetype: Standard Business
Treasury beta 1y: 0.03806624717262356 (R-squared: 0.0002290972929496614)
Insider 90-day net shares: 50000 (net value USD: 24710.00)
ROIC (%): -7885.834737827496 (pretax: -9982.069288389235)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 31.67870036101083, ROIC 46.11913357400722, revenue growth 1y , 6m momentum 53.33935018050542
Sector percentiles: P/E , 6m momentum 59.634670487106014
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.058074183630195945
Base cash flow: -29326142.85714286
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1559.HK (Industrials — Engineering & Construction, Hong Kong)
Report date: 2025-09-30 (quarterly)
Stock price: 0.005102040816326531
Market cap: 115693216 (USD: 14870593.316195372)
P/B ratio: 4.032204435336309
Debt to equity: 0.1393
Current ratio: 1.5
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.24115502157014923
Total shareholder yield (%): 0.24115502157014923 (Low Return)
Momentum (%): 1m 0, 3m -20.10204081632653, 6m -55.78231292517006, 12m -59.94897959183674, composite -45.27777777777778 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.4693270383290065 (Likely Safe)
Equity multiplier (leverage): 4.321313854719361
ROE archetype: Standard Business
Treasury beta 1y: 0.7937786819154465 (R-squared: 0.04654699468683831)
Insider 90-day net shares: 50000 (net value USD: 581.00)
ROIC (%): -59.675311687445834 (pretax: -75.53836922461498)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 69.08462867012089, ROIC 85.146804835924, revenue growth 1y , 6m momentum 91.19170984455958
Sector percentiles: P/E , 6m momentum 84.17818740399386
Industry median P/E: 0.3073205413493449; industry median ROIC: 8.170542376375224
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.09345940742130321
Base cash flow: -9516195.372750644
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1712.HK (Basic Materials — Gold, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.6428571428571429
Market cap: 956168320 (USD: 641723704.6979866)
P/E ratio: 0.42520318869933266
P/B ratio: 1.3018155585050901
Debt to equity: 0.0019
Current ratio: 6.5
Interest coverage ratio: 62.40767973856209
Return on net tangible assets (%): 27.019621221291718
Buffett classification: The Great
Rule of 40 score: 156.54431026698924
Altman Z-score: 11.295873266947766 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 25.14566558473622, earnings yield % 6.063544822682993, rank 1228
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0038345336805649353
Total shareholder yield (%): 0.0038345336805649353 (Low Return)
Momentum (%): 1m 3.703703703703703, 3m -39.42753996905621, 6m -41.00840336134454, 12m 40.569040986868295, composite -14.96240841197354 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 13, short score 0, recommendation: Strong Long (L/S Compounder)
Revenue deceleration: no
Beneish M-score: -2.49933403052644 (Likely Safe)
Equity multiplier (leverage): 1.4403583734985261
ROE archetype: Standard Business
P/E z-score: 4.6763005996366
FCF z-score: 4.676300599636606
Treasury beta 1y: -0.02226633223672591 (R-squared: 6.523654048814596e-05)
Insider 90-day net shares: -322602 (net value USD: -218395.00)
ROIC (%): 58.80960548584399 (pretax: 73.47588541967257)
Incremental ROIC 3y (%): 113.99062596702383 (pretax: 141.20797946727976)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 2.4079320113314444, P/B 12.889518413597735, ROIC 1.2747875354107647, revenue growth 1y , 6m momentum 58.07365439093485
Sector percentiles: P/E 15.04719600222099, 6m momentum 64.46418656302055
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.11301067511387203
Base cash flow: 32957046.97986577
DCF price per share: base 0.8641290608625882, conservative 0.5289141206927421, aggressive 1.445748240397289
Financial scorecard for 1722.HK (Industrials — Engineering & Construction, Macau)
Report date: 2025-12-31 (annual)
Stock price: 0.015306122448979591
Market cap: 126500000 (USD: 16259640.102827763)
P/B ratio: 0.6241046226294662
Debt to equity: 0.7826000000000001
Current ratio: 1.06
Interest coverage ratio: -4.330294050604057
Return on net tangible assets (%): -9.645253258819022
Buffett classification: The Gruesome
Rule of 40 score: -6.4689043714083105
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -7.6456916996047415
Total shareholder yield (%): -7.6456916996047415 (Minimal or Negative)
Momentum (%): 1m 19.999999999999996, 3m 99.74489795918367, 6m 32.65306122448979, 12m 100.25510204081631, composite 66.42573696145125 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.0364691982129236
FCF conversion rate: 0.18779390200738233
Beneish M-score: -3.769475882014293 (Likely Safe)
Equity multiplier (leverage): 2.8570787948021636
ROE archetype: Standard Business
Treasury beta 1y: -0.039517905790109775 (R-squared: 6.835101820315475e-05)
Insider 90-day net shares: 23050000 (net value USD: 290430.00)
ROIC (%): -6.46189848782336 (pretax: -8.179618339016912)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 19.170984455958546, ROIC 78.06563039723662, revenue growth 1y , 6m momentum 14.507772020725387
Sector percentiles: P/E , 6m momentum 11.392729134664618
Industry median P/E: 0.3073205413493449; industry median ROIC: 8.170542376375224
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: -1748071.979434447
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1828.HK (Financial Services — Insurance - Life, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 3.7525510204081636
Market cap: 37540073472 (USD: 4825202245.758354)
P/E ratio: 4.959621926202903
P/B ratio: 7.0878873900538
Debt to equity: 0.49
Current ratio: 3.86
Return on net tangible assets (%): 4.245933278191343
Buffett classification: The Gruesome
Analyst consensus upside (%): 778.4068062827226
Rule of 40 score: 23.804037300407465
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.6753539006911182
Total shareholder yield (%): -0.6753539006911182 (Minimal or Negative)
Momentum (%): 1m 1.658604008293028, 3m -4.04155947160052, 6m -21.946938775510194, 12m -22.683660078204507, composite -16.644535928996554 (Strong Downtrend)
Lynch category:  (confidence: Medium)
Screener: long score 6, short score 2, recommendation: Neutral
Revenue growth 1y (%): 20.518530958132565
Net income growth 1y (%): 589.8886032562124
Revenue CAGR 3y (%): 28.24356296281416
Revenue deceleration: yes
Revenue growth consistency score: 7.338068383117459
Accrual ratio: 0.00013767771580604956
FCF conversion rate: 0.9518072289156626
Beneish M-score: -2.482972199569881 (Likely Safe)
ROE (%): 2.4218441255577727
Net margin (%): 3.451861093782491
Asset turnover: 0.08276151691391143
Equity multiplier (leverage): 8.477434337258563
ROE archetype: Low Return
P/E z-score: 2.409064105618292
FCF z-score: 2.40906410561829
Treasury beta 1y: -0.03319540229133333 (R-squared: 0.0017352368002697505)
Insider 90-day net shares: 2104300 (net value USD: 7985067.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 48.4375, P/B 78.125, ROIC , revenue growth 1y 21.875, 6m momentum 87.5
Sector percentiles: P/E 22.736678737713397, 6m momentum 60.7604759441283
Industry median P/E: 2.40435505821866; industry median ROIC: 2.783940447395565
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10135971464391338
Base cash flow: 19794344.473007713
DCF price per share: base 0.6890230387572222, conservative 0.6523610786373181, aggressive 0.7537758466564877
Financial scorecard for 1945.HK (Financial Services — Financial Conglomerates, China)
Report date: 2025-12-31 (annual)
Stock price: 0.1913265306122449
Market cap: 441323424 (USD: 63046203.428571425)
P/E ratio: 0.6998000571265351
P/B ratio: 0.6097858458007007
Debt to equity: 0.0863
Current ratio: 2.06
Interest coverage ratio: 16.7592936802974
Return on net tangible assets (%): 13.864737641461671
Buffett classification: The Great
Rule of 40 score: 47.51258431851378
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.5048451722335953
Debt paydown yield (%): 1.4376621273624934
Total shareholder yield (%): 1.9425072995960888 (Low Return)
Momentum (%): 1m -13.793103448275865, 3m -16.77295918367347, 6m -7.879818594104318, 12m 19.19946550048589, composite 4.539534067595283 (Strong Uptrend)
Lynch category: Asset Play (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 25.70070338645285
Net income growth 1y (%): 498.79502299662863
Revenue CAGR 3y (%): 1.4950376137271348
Net income CAGR 3y (%): 51.23238766228133
FCF CAGR 3y (%): 85.62965956322688
Revenue deceleration: no
Revenue growth consistency score: 23.636343438741147
Accrual ratio: 0.02160942417434771
FCF conversion rate: 0.7147154781577052
Beneish M-score: -3.230175135638918 (Likely Safe)
Equity multiplier (leverage): 1.5641917511081236
ROE archetype: Standard Business
P/E z-score: 4.437488234529445
FCF z-score: 4.437488234529448
Treasury beta 1y: 0.2532745321446566 (R-squared: 0.020580535899876202)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 24.67088596851463 (pretax: 29.867580929666378)
Incremental ROIC 3y (%): 7.464769843523496 (pretax: 9.134912871916674)
Capital allocation category: Fading Compounder
Industry percentiles: P/E 29.166666666666668, P/B 18.75, ROIC 4.166666666666666, revenue growth 1y 22.916666666666664, 6m momentum 47.91666666666667
Sector percentiles: P/E 14.071391619244697, 6m momentum 51.73305742369374
Industry median P/E: 1.3712598365400772; industry median ROIC: 5.442107665372286
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.05
Base cash flow: 12597857.142857142
DCF price per share: base 0.2432813631202558, conservative 0.19983737231510715, aggressive 0.3094148037849752
Financial scorecard for 2105.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.826530612244898
Market cap: 2910247936 (USD: 415749705.14285713)
P/B ratio: 4.659273303915875
Debt to equity: 0.1024
Current ratio: 5.54
Interest coverage ratio: -68.11615900877646
Return on net tangible assets (%): -21.14587768581309
Buffett classification: The Gruesome
Analyst consensus upside (%): 1322.8082292432036
Rule of 40 score: -177.6778268162183
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.31492521613493374
Total shareholder yield (%): -0.31492521613493374 (Minimal or Negative)
Momentum (%): 1m -2.7027027027027026, 3m -58.62062216190825, 6m -59.554963767188184, 12m -64.58370466090366, composite -60.59183486945284 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.5554727057206192 (Likely Safe)
Equity multiplier (leverage): 1.22931583625071
ROE archetype: Standard Business
Treasury beta 1y: 0.17226724111092775 (R-squared: 0.0057444352957489635)
Insider 90-day net shares: 139346 (net value USD: 128594.00)
ROIC (%): -536.9533793529788 (pretax: -679.6878219657959)
Incremental ROIC 3y (%): 4.621152511624966 (pretax: 5.849560141297425)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 44.13357400722022, ROIC 38.537906137184116, revenue growth 1y , 6m momentum 70.3971119133574
Sector percentiles: P/E , 6m momentum 73.81805157593124
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -31997428.57142857
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2121.HK (Technology — Software - Infrastructure, China)
Report date: 2025-12-31 (annual)
Stock price: 0.4897959183673469
Market cap: 1994431232 (USD: 284918747.4285714)
P/B ratio: 1.912092339463501
Debt to equity: 0.1324
Current ratio: 2.24
Interest coverage ratio: -31.62142370572207
Return on net tangible assets (%): -22.47666983994176
Buffett classification: The Gruesome
Rule of 40 score: 18.97617865502282
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 9.904126892453318
Debt paydown yield (%): 0.6398425261965714
Total shareholder yield (%): 10.54396941864989 (High Return)
Momentum (%): 1m -5.185185185185189, 3m -0.9017560512577161, 6m -40.3061224489796, 12m -44.11485524442335, composite -27.422171630280022 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue growth 1y (%): 29.10650093026781
Revenue CAGR 3y (%): -1.1632545525687599
Revenue deceleration: no
Revenue growth consistency score: 31.288598225056084
Accrual ratio: -0.07715837527019995
FCF conversion rate: 0.2591404591935173
Beneish M-score: -2.7522796089968393 (Likely Safe)
ROE (%): -16.46098776701654
Net margin (%): -16.44789819630057
Asset turnover: 0.6331939938471474
Equity multiplier (leverage): 1.5805516634566896
ROE archetype: Low Return
Treasury beta 1y: 0.04401435198966268 (R-squared: 0.0007027073623257806)
Insider 90-day net shares: -231208 (net value USD: -123222.00)
ROIC (%): -21.03337080552791 (pretax: -26.624520006997354)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 26.69683257918552, ROIC 57.692307692307686, revenue growth 1y 17.420814479638008, 6m momentum 72.17194570135746
Sector percentiles: P/E , 6m momentum 72.80613947280614
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.0858431998165855
Base cash flow: -29243142.857142854
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2228.HK (Healthcare — Health Information Services, China)
Report date: 2025-12-31 (annual)
Stock price: 0.9183673469387755
Market cap: 30984275968 (USD: 4426325138.285714)
P/E ratio: 40.531276778063415
P/B ratio: 3.8838953155068667
Debt to equity: 0.046900000000000004
Current ratio: 14.77
Interest coverage ratio: -48.04407684098186
Return on net tangible assets (%): 1.9951264969869285
Buffett classification: The Gruesome
Analyst consensus upside (%): 770.1099365750528
Rule of 40 score: 168.4666405556002
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.2725195042324879
Total shareholder yield (%): -0.2725195042324879 (Minimal or Negative)
Momentum (%): 1m 2.7104136947218302, 3m -13.571919152276294, 6m -46.86004965784534, 12m 21.162750814611552, composite -14.155522788076333 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.3050360355703146 (Likely Safe)
Equity multiplier (leverage): 1.0895935907542216
ROE archetype: Standard Business
P/E z-score: 1.5626657463711642
Treasury beta 1y: -0.026581965288363957 (R-squared: 0.00019573238005874227)
Insider 90-day net shares: -50000 (net value USD: -61475.00)
ROIC (%): -15.859842651865133 (pretax: -15.951646108762594)
Incremental ROIC 3y (%): -1.325257796229979 (pretax: 2.4531679153580592)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 29.47368421052631, P/B 42.63157894736842, ROIC 42.10526315789473, revenue growth 1y , 6m momentum 68.42105263157895
Sector percentiles: P/E 30.19340974212034, 6m momentum 68.69627507163324
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11929990982261222
Base cash flow: 26080000
DCF price per share: base 0.06354479652892521, conservative 0.052856441036853934, aggressive 0.0819342680314605
Financial scorecard for 2251.HK (Healthcare — Health Information Services, China)
Report date: 2025-12-31 (annual)
Stock price: 1.2602040816326532
Market cap: 998317824 (USD: 142616832)
P/B ratio: 0.8501666542487486
Debt to equity: 0.022000000000000002
Current ratio: 10.53
Interest coverage ratio: -80.91594202898551
Return on net tangible assets (%): -0.44177982971803476
Buffett classification: The Gruesome
Analyst consensus upside (%): 784.1837270341208
Rule of 40 score: -3.855273985618828
Altman Z-score: 6.712167831728279 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.2898697880004997
Debt paydown yield (%): 0.3654929055857273
Total shareholder yield (%): 1.655362693586227 (Low Return)
Momentum (%): 1m -7.921714818266541, 3m -17.565597667638478, 6m -17.536981235447197, 12m -23.31316247429204, composite -17.272729855318488 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.0003588882882447494
FCF conversion rate: 0.9803808898374651
Beneish M-score: -2.2232198635815474 (Likely Safe)
Equity multiplier (leverage): 1.0888470896112858
ROE archetype: Standard Business
Treasury beta 1y: -7.13956050380218e-05 (R-squared: 2.911355654570389e-09)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -3.6820932876751202 (pretax: -4.660877579335596)
Incremental ROIC 3y (%): 34.060825205884996 (pretax: 43.11496861504429)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 12.105263157894736, ROIC 35.78947368421053, revenue growth 1y , 6m momentum 41.05263157894737
Sector percentiles: P/E , 6m momentum 47.70773638968481
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09113788136438297
Base cash flow: -675285.7142857143
DCF price per share: base 0.09196473313288918, conservative 0.10971000706943082, aggressive 0.06060337177605983
Financial scorecard for 2605.HK (Communication Services — Advertising Agencies, China)
Report date: 2025-12-31 (annual)
Stock price: 0.14285714285714288
Market cap: 172789728 (USD: 24684246.85714286)
P/B ratio: 1.0050368522880992
Debt to equity: 0.0349
Current ratio: 8.46
Interest coverage ratio: 1.6341463414634145
Return on net tangible assets (%): -35.082083223346125
Buffett classification: The Great
Rule of 40 score: -4.9993527889545355
Altman Z-score: 2.2924683711124 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 10.174953208215445
Total shareholder yield (%): 10.174953208215445 (High Return)
Momentum (%): 1m -0.8849557522123617, 3m -23.385518590998025, 6m -48.885976408912185, 12m -81.08889424235123, composite -51.06384669457034 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.44153913119403304
FCF conversion rate: -0.06351072752784767
Beneish M-score: -2.2765612069969188 (Likely Safe)
Equity multiplier (leverage): 1.1696663695845624
ROE archetype: Standard Business
FCF z-score: 2.353612656426971
Treasury beta 1y: -0.06283869616720464 (R-squared: 0.0017210866783832128)
Insider 90-day net shares: 0 (net value USD: 15473.00)
ROIC (%): 1.3998325031956618 (pretax: 1.771939877462863)
Incremental ROIC 3y (%): -6.690353646122375 (pretax: -8.468802083699208)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 23.134328358208954, ROIC 50, revenue growth 1y , 6m momentum 79.1044776119403
Sector percentiles: P/E , 6m momentum 76.89178193653376
Industry median P/E: 0.20627847567967422; industry median ROIC: 5.9821146700167755
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.10134148474002348
Base cash flow: -17846857.142857146
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2618.HK (Industrials — Integrated Freight & Logistics, China)
Report date: 2026-03-31 (quarterly)
Stock price: 1.7844387755102042
Market cap: 85699248128 (USD: 12402206675.542692)
P/E ratio: 1.4508928571428572
Debt to equity: 0.37549999999999994
Buffett classification: The Gruesome
Analyst consensus upside (%): 953.374358974359
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 12.600987867631682, earnings yield % 1.0709110792144607, rank 3646
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 19.368600682593865, 3m -7.713635322028405, 6m 22.30775438470643, 12m 0.05603134110787817, composite -0.528272265793427 (Strong Downtrend)
Lynch category:  (confidence: Medium)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
P/E z-score: 4.324192180438229
FCF z-score: 5.131124250090375
Treasury beta 1y: 0.03192227119372957 (R-squared: 0.0007200379860579591)
Insider 90-day net shares: -960552 (net value USD: -1723326.00)
ROIC (%): 11.211987692040024 (pretax: 11.931649400607197)
Incremental ROIC 3y (%): 49.58720866941942 (pretax: 52.12688455771326)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 34.41558441558442, P/B , ROIC 17.532467532467532, revenue growth 1y , 6m momentum 14.285714285714285
Sector percentiles: P/E 39.887352790578596, 6m momentum 16.231438812083972
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.07409991684221075
Base cash flow: 1814325857.142857
DCF price per share: base 2.3981440062179273, conservative 1.300677448961042, aggressive 4.464492327185403
Financial scorecard for 2889.HK (Technology — Software - Application, China)
Report date: 2025-12-31 (annual)
Stock price: 16.56887755102041
Market cap: 21019969536 (USD: 3002852790.857143)
P/B ratio: 7.5220044421859695
Debt to equity: 1.0458
Current ratio: 1.48
Interest coverage ratio: -16.598161640272902
Return on net tangible assets (%): -71.05141004392317
Buffett classification: The Gruesome
Analyst consensus upside (%): 853.8022099447513
Rule of 40 score: -10.010590886946183
Altman Z-score: 3.1745669676711565 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.893772164395873
Total shareholder yield (%): -2.893772164395873 (Minimal or Negative)
Momentum (%): 1m -1.9622641509433916, 3m -16.354409268542984, 6m -47.293130139494615, 12m , composite -31.8237697040188 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 11, recommendation: Short
Revenue growth 1y (%): 43.141905917647684
Revenue CAGR 3y (%): 42.039104620018364
Revenue deceleration: yes
Revenue growth consistency score: 23.126370234657436
Accrual ratio: -0.009151390943862787
FCF conversion rate: 0.9582824184508216
Beneish M-score: -2.5613614051055533 (Likely Safe)
ROE (%): -60.167309836710736
Net margin (%): -31.15137762890892
Asset turnover: 0.7041914172423245
Equity multiplier (leverage): 2.742790325650959
ROE archetype: Low Return
Treasury beta 1y: -0.11220281011403066 (R-squared: 0.0019599072698126877)
Insider 90-day net shares: 234580 (net value USD: 5134424.00)
ROIC (%): -26.573015053608163 (pretax: -33.636727915959696)
Incremental ROIC 3y (%): -19.54921514953466 (pretax: -24.745841961436277)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 61.99460916442049, ROIC 63.47708894878706, revenue growth 1y 7.008086253369273, 6m momentum 82.61455525606469
Sector percentiles: P/E , 6m momentum 76.34300967634302
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10066192769259048
Base cash flow: -218449285.71428573
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 3LN.DE (Communication Services — Entertainment, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 176.8181818181818
Market cap: 36210114560 (USD: 36210114560)
P/E ratio: 128.21967869494458
P/B ratio: 23.650403992709837
Debt to equity: 7.3827
Current ratio: 0.89
Interest coverage ratio: -4.1596297032765515
Buffett classification: The Gruesome
Rule of 40 score: 12.729347532642066
Altman Z-score: 0.8212052427278432 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 23.56477628078101, earnings yield % 3.1375221619825986, rank 1918
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.49438396474380003
Total shareholder yield (%): -0.49438396474380003 (Minimal or Negative)
Momentum (%): 1m , 3m 12.665258279950933, 6m 26.458102267946614, 12m , composite 19.561680273948774 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 8, recommendation: Short
Revenue growth 1y (%): 12.149550119052655
Net income growth 1y (%): -920.7377651073389
Revenue deceleration: no
Accrual ratio: -0.09840115351733467
FCF conversion rate: -5.3414759300875225
Beneish M-score: -3.0586923625377005 (Likely Safe)
ROE (%): -23.368545398474783
Net margin (%): -10.018853006396734
Asset turnover: 0.15487875052635608
Equity multiplier (leverage): 15.059891359858861
ROE archetype: Low Return
P/E z-score: 3.828684501168573
FCF z-score: 3.828684501168574
Treasury beta 1y: 0.1691197553024134 (R-squared: 0.0021149530890061303)
Insider 90-day net shares: -158969 (net value USD: -26302423.00)
ROIC (%): 16.109173485806462 (pretax: 24.033555642944783)
Incremental ROIC 3y (%): 13.166954276024615 (pretax: 23.870647952144353)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 47.64150943396226, P/B 63.67924528301887, ROIC 9.433962264150944, revenue growth 1y 24.056603773584907, 6m momentum 13.20754716981132
Sector percentiles: P/E 50.772986167615954, 6m momentum 8.868999186330349
Industry median P/E: 3.7313797891504157; industry median ROIC: 1.542068936425999
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.08741565940440563
Base cash flow: 247107000
DCF price per share: base 30.06009941329033, conservative 9.839572711456757, aggressive 67.06611025466349
Financial scorecard for 3SM.DE (Industrials — Specialty Industrial Machinery, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 61
Debt to equity: 0.34979999999999994
Current ratio: 1.56
Interest coverage ratio: 22.788732394366196
Return on net tangible assets (%): 36.57111049262455
Buffett classification: The Great
Rule of 40 score: 15.503454789884803
Piotroski F-score: 5 (Neutral)
Momentum (%): 1m 5.0900548159749395, 3m , 6m , 12m , composite  ()
Lynch category: Slow Grower (confidence: High)
Screener: long score 6, short score 0, recommendation: Neutral
Revenue growth 1y (%): -1.8985371926548367
Net income growth 1y (%): -13.616398243045392
Revenue deceleration: no
Accrual ratio: -0.00026497475379429127
FCF conversion rate: 1.0076271186440677
Beneish M-score: -2.3698060151861533 (Likely Safe)
ROE (%): 6.317085575095693
Net margin (%): 12.478849407783418
Asset turnover: 0.2784001413198687
Equity multiplier (leverage): 1.8183302550924811
ROE archetype: Standard Business
Treasury beta 1y: -0.07130315090534523 (R-squared: 0.010857450394967138)
Insider 90-day net shares: -1460 (net value USD: -110565.00)
ROIC (%): 29.94523880774732 (pretax: 39.20512682427702)
Incremental ROIC 3y (%): 15.921525846077628 (pretax: 30.923694779116467)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E , P/B , ROIC 5.394990366088632, revenue growth 1y 39.691714836223504, 6m momentum 
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05367738144470535
Base cash flow: 560500000
Financial scorecard for 6928.HK (Consumer Cyclical — Auto Parts, Singapore)
Report date: 2025-12-31 (annual)
Stock price: 0.02295918367346939
Market cap: 139230000 (USD: 108773437.5)
P/B ratio: 2.5794805181836162
Debt to equity: 0.0074
Current ratio: 4.26
Interest coverage ratio: -816.6999790488162
Return on net tangible assets (%): -27.050145645461
Buffett classification: The Gruesome
Rule of 40 score: -82.11837457754909
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.06822295735790546
Total shareholder yield (%): -0.06822295735790546 (Minimal or Negative)
Momentum (%): 1m -9.999999999999998, 3m -21.83895297249335, 6m -25.38265306122448, 12m -67.81614431486881, composite -37.153922127857356 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 13.872572925284743
Revenue CAGR 3y (%): -42.07343953531924
Revenue deceleration: no
Revenue growth consistency score: 42.76687783380536
Accrual ratio: -0.05965190350882089
FCF conversion rate: 0.7850186494594393
Beneish M-score: -3.955532239564505 (Likely Safe)
ROE (%): -31.36414028772936
Net margin (%): -122.27855678197305
Asset turnover: 0.22692023027045766
Equity multiplier (leverage): 1.1303420077118924
ROE archetype: Low Return
Treasury beta 1y: -0.11906463770454087 (R-squared: 0.0010478388586836298)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -77.92020172423565 (pretax: -98.63316673953881)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 64.46280991735537, ROIC 92.56198347107438, revenue growth 1y 15.977961432506888, 6m momentum 77.96143250688705
Sector percentiles: P/E , 6m momentum 70.96662030598053
Industry median P/E: 0.2842479295922772; industry median ROIC: 7.591641841963527
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.14583819248440733
Base cash flow: -2801125
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 6955.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.6288265306122449
Market cap: 3068104960 (USD: 438300708.5714286)
P/E ratio: 109.25449871465295
P/B ratio: 1.73711284588911
Debt to equity: 0.2859
Current ratio: 2.33
Interest coverage ratio: 1.0494593615810441
Return on net tangible assets (%): 1.703516124789703
Buffett classification: The Gruesome
Rule of 40 score: -15.667837722804808
Altman Z-score: 1.697202856709831 (Distress Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 2.2090909783926183, earnings yield % 0.21300105071417985, rank 5535
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -4.10383077691183
Total shareholder yield (%): -4.10383077691183 (Minimal or Negative)
Momentum (%): 1m 7.173913043478277, 3m -25.171554183983623, 6m -44.199693529288844, 12m -71.792638483965, composite -47.68400191025506 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 3, short score 7, recommendation: Neutral
Revenue growth 1y (%): 12.686107502991618
Net income growth 1y (%): -89.82064049437561
Revenue CAGR 3y (%): 14.785961927344982
Revenue deceleration: yes
Revenue growth consistency score: 2.3148677975393936
Accrual ratio: 0.0630640894630398
FCF conversion rate: -29.277435610302355
Beneish M-score: -2.061187954024779 (Likely Safe)
ROE (%): 0.3310195178295308
Net margin (%): 0.9102700994620436
Asset turnover: 0.2288193582147267
Equity multiplier (leverage): 1.5892439298137853
ROE archetype: Low Return
P/E z-score: 2.9663545350207663
Treasury beta 1y: 0.0735492528525773 (R-squared: 0.0017707317050586278)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 1.6955308114767833 (pretax: 1.6955308114767833)
Incremental ROIC 3y (%): 33.130528555025926 (pretax: 40.74548642823757)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 13.267148014440433, P/B 20.216606498194945, ROIC 8.935018050541517, revenue growth 1y 14.440433212996389, 6m momentum 62.63537906137184
Sector percentiles: P/E 33.27363896848137, 6m momentum 67.40687679083095
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: 3201142.857142858
DCF price per share: base 0.15081692108459396, conservative 0.07914235036402131, aggressive 0.3094243543408767
Financial scorecard for 9926.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 12.691326530612246
Market cap: 91653742592 (USD: 13093391798.857143)
P/B ratio: 10.478072056638975
Debt to equity: 0.5093
Current ratio: 5.14
Interest coverage ratio: -6.4719836307137895
Return on net tangible assets (%): -18.656311573228727
Buffett classification: The Gruesome
Analyst consensus upside (%): 1065.07391688771
Rule of 40 score: -11.834082484766235
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.13289713198100347
Total shareholder yield (%): -0.13289713198100347 (Minimal or Negative)
Momentum (%): 1m 13.714285714285715, 3m -24.488535915886107, 6m -15.028028378733463, 12m -35.13872834289965, composite -27.49258585366287 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.546854076865796 (Likely Safe)
Equity multiplier (leverage): 1.9121860206956216
ROE archetype: Standard Business
Treasury beta 1y: -0.1253144629392519 (R-squared: 0.004690573156519005)
Insider 90-day net shares: 200000 (net value USD: 2318060.00)
ROIC (%): -15.31053242137917 (pretax: -19.38042078655591)
Incremental ROIC 3y (%): 13.553461395348624 (pretax: 17.15628024727674)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 58.12274368231047, ROIC 13.898916967509026, revenue growth 1y , 6m momentum 38.35740072202166
Sector percentiles: P/E , 6m momentum 44.73495702005731
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -232574857.14285713
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 9939.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.21556122448979592
Market cap: 792447680 (USD: 113206811.42857143)
P/B ratio: 4.528632909851245
Debt to equity: 0.4743
Current ratio: 0.43
Interest coverage ratio: -51.385654056795126
Return on net tangible assets (%): -270.54385834387324
Buffett classification: The Gruesome
Rule of 40 score: -5176.934293661164
Altman Z-score: -16.20891969761568 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.16066352008468565
Total shareholder yield (%): -0.16066352008468565 (Minimal or Negative)
Momentum (%): 1m -22.8310502283105, 3m -37.71791927102945, 6m -40.58736568832481, 12m -28.601029019202628, composite -28.594119355692794 (Moderate Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -30.775551657142863
Revenue deceleration: no
Beneish M-score: -2.5017764511909455 (Likely Safe)
ROE (%): -86.14338483014708
Net margin (%): -6029.170886336057
Asset turnover: 0.007951887434476917
Equity multiplier (leverage): 1.7967767344276184
ROE archetype: Low Return
Treasury beta 1y: 0.044523738869795014 (R-squared: 0.00031529114145640365)
Insider 90-day net shares: 1421000 (net value USD: 432458.00)
ROIC (%): -67.71013989181964 (pretax: -85.70903783774638)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 43.501805054151625, ROIC 22.111913357400724, revenue growth 1y 21.931407942238266, 6m momentum 60.83032490974729
Sector percentiles: P/E , 6m momentum 65.72349570200574
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -25974142.85714286
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ACDC.V (Basic Materials — Other Precious Metals & Mining, Canada)
Report date: 2026-01-31 (quarterly)
Stock price: 0.03546099290780142
Market cap: 2594252 (USD: 1921668.148148148)
P/B ratio: 2.5555304377317123
Debt to equity: 0
Current ratio: 83.5051857300478
Return on net tangible assets (%): -5.647007169227976
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 114.32724451256374 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560311, 3m -2.8368794326240985, 6m -30.091185410334354, 12m -3.546099290780138, composite -12.384472318544837 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.007772361408145819
FCF conversion rate: 0.8597737240829346
Beneish M-score: -2.935347772111948 (Likely Safe)
ROE (%): -5.594584916381461
Asset turnover: 0
Equity multiplier (leverage): 1.0093558018336044
ROE archetype: Low Return
Treasury beta 1y: -0.0008640625118856965 (R-squared: 5.673354997639591e-06)
Insider 90-day net shares: 3000000 (net value USD: 111000.00)
ROIC (%): -70.59679689858436 (pretax: -89.36303404884094)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 23.78223495702006, ROIC 42.12034383954155, revenue growth 1y , 6m momentum 38.68194842406877
Sector percentiles: P/E , 6m momentum 54.108828428650746
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: -224743.4782608696
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ACEL (Consumer Cyclical — Gambling, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 12.03
Market cap: 979156544 (USD: 979156544)
P/E ratio: 18.183333333333334
P/B ratio: 3.213431831916595
Debt to equity: 2.1009
Current ratio: 2.71
Interest coverage ratio: 3.1855075873426655
Return on net tangible assets (%): -11.074234449140457
Buffett classification: The Gruesome
Analyst consensus upside (%): 42.07149404216315
Rule of 40 score: 7.906652430547416
Altman Z-score: 1.6374219166762352 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 4.928968611497893, earnings yield % 2.099725250485747, rank 805
Dividend yield (%): 0
Buyback yield (%): 1.2404553770719629
Debt paydown yield (%): 2.7430751665384365
Total shareholder yield (%): 3.9835305436103994 (Low Return)
Momentum (%): 1m -7.8866768759571295, 3m -2.2745735174654844, 6m 6.5544729849424295, 12m -3.218020917135964, composite 3.1160941373220297 (Flat)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): 8.535034206821601
Net income growth 1y (%): 0.23225630165994993
Revenue deceleration: no
Accrual ratio: -0.004792523993659631
FCF conversion rate: 1.3551420977305255
Beneish M-score: -2.753426204421725 (Likely Safe)
ROE (%): 5.334647029096422
Net margin (%): 4.17370675677982
Asset turnover: 0.32332568608002166
Equity multiplier (leverage): 3.953152324478006
ROE archetype: Standard Business
P/E z-score: 4.3129966874383125
FCF z-score: 4.312996687438305
Treasury beta 1y: -0.0012961739779156838 (R-squared: 0.00023681112912419996)
Insider 90-day net shares: -54277 (net value USD: -682501.00)
ROIC (%): 13.149731852417412 (pretax: 18.448146393279703)
Incremental ROIC 3y (%): 0.9460390232333477 (pretax: 9.150141878791409)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 25.396825396825395, P/B 44.44444444444444, ROIC 12.698412698412698, revenue growth 1y 14.285714285714285, 6m momentum 20.634920634920633
Sector percentiles: P/E 52.53824756606398, 6m momentum 23.12239221140473
Industry median P/E: 16.180729951448185; industry median ROIC: 5.072451584604492
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.07780725364644778
Base cash flow: 42322000
DCF price per share: base 16.06220725570491, conservative 8.28097915349053, aggressive 29.237856445299887
Financial scorecard for ADMA (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 8.27
Market cap: 1916760448 (USD: 1916760448)
P/E ratio: 13.44776119402985
P/B ratio: 5.350085600845449
Debt to equity: 1.1067
Current ratio: 6.95
Interest coverage ratio: 23.94952380952381
Return on net tangible assets (%): 11.555682156591095
Buffett classification: The Great
Analyst consensus upside (%): 88.67924528301887
Rule of 40 score: 25.352949814270765
Altman Z-score: 5.1504670816139715 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 9.880088951053347, earnings yield % 0.11518332570607523, rank 1428
Dividend yield (%): 0
Buyback yield (%): 6.792241572797729
Debt paydown yield (%): -6.496429959723376
Total shareholder yield (%): 0.29581161307435266 (Low Return)
Momentum (%): 1m -4.942528735632181, 3m -26.554174067495563, 6m -50.56784219964137, 12m -52.224147891392256, composite -42.28735030972733 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 6, short score 0, recommendation: Neutral
Revenue growth 1y (%): -0.26915907388372906
Net income growth 1y (%): 68.48052334225395
Revenue deceleration: no
Accrual ratio: -0.016014877937935174
FCF conversion rate: 1.2277841510765972
Beneish M-score: -3.046101568794799 (Likely Safe)
ROE (%): 10.448512928674745
Net margin (%): 39.59019328692584
Asset turnover: 0.17758754670682925
Equity multiplier (leverage): 1.4861216280852192
ROE archetype: Standard Business
P/E z-score: 2.7949577205768366
FCF z-score: 3.67147805570551
Treasury beta 1y: 0.006588719929831003 (R-squared: 0.002912224048128562)
Insider 90-day net shares: 31400 (net value USD: 250874.00)
ROIC (%): 32.79525860927188 (pretax: 40.76941915561944)
Incremental ROIC 3y (%): 74.13326829614125 (pretax: 92.44115491366985)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 8.844765342960288, P/B 47.74368231046932, ROIC 2.436823104693141, revenue growth 1y 17.779783393501805, 6m momentum 66.87725631768953
Sector percentiles: P/E 20.916905444126073, 6m momentum 70.66618911174784
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08676336750848145
Base cash flow: 132451000
DCF price per share: base 24.63270440276745, conservative 13.75853975158763, aggressive 44.39570300549966
Financial scorecard for ADPT (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 22.27
Market cap: 3564188416 (USD: 3564188416)
P/B ratio: 9.906378231277955
Debt to equity: 0.9284
Current ratio: 3.35
Interest coverage ratio: -6.64797507788162
Return on net tangible assets (%): -17.670022173410647
Buffett classification: The Gruesome
Analyst consensus upside (%): 60.59077809798269
Rule of 40 score: -32.535082853693616
Altman Z-score: 4.264052599805765 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.04264645474904097
Total shareholder yield (%): 0.04264645474904097 (Low Return)
Momentum (%): 1m 15.149948293691828, 3m 57.49646393210749, 6m 20.05390835579514, 12m 108.91181988742964, composite 52.99208782329712 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 7, recommendation: Neutral
Revenue growth 1y (%): 35.14482390404821
Revenue deceleration: no
Accrual ratio: -0.019008932156253343
FCF conversion rate: 0.5162628028978267
Beneish M-score: -2.586899018437042 (Likely Safe)
ROE (%): -8.9105649071102
Net margin (%): -28.240257358128513
Asset turnover: 0.13914883883932033
Equity multiplier (leverage): 2.2675506742468423
ROE archetype: Low Return
Treasury beta 1y: -0.0011675508175936335 (R-squared: 5.464048022782597e-05)
Insider 90-day net shares: -1549850 (net value USD: -32557136.00)
ROIC (%): -58.47836566496909 (pretax: -74.02324767717606)
Incremental ROIC 3y (%): 3461.5549770290963 (pretax: 4381.715160796325)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 64.70588235294117, ROIC 66.91176470588235, revenue growth 1y 8.088235294117647, 6m momentum 16.176470588235293
Sector percentiles: P/E , 6m momentum 14.398280802292263
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -44583000
DCF price per share: base 0, conservative 0, aggressive 0